Global Therapeutic Proteins Market 2026 growing with biologics expansion

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Therapeutic Proteins Market By The End Of 2030?

The therapeutic proteins market has seen substantial growth recently. Its size is expected to expand from $177.3 billion in 2025 to $200.43 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.0%. This historical growth can be linked to the successful widespread use of insulin therapies, an increasing occurrence of chronic illnesses, the notable clinical effectiveness of protein medications, advancements in biotechnology research, and a rise in regulatory approvals.

The therapeutic proteins market is projected to experience swift expansion over the coming years, reaching a size of $332.37 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.5%. This anticipated growth during the forecast period is driven by factors such as the expanding pipelines in oncology and immunology, an increase in biologics approvals, greater investment in biopharmaceutical R&D, a rising uptake of biosimilars, and enhanced manufacturing scalability. Key trends expected in the forecast period encompass the proliferation of recombinant protein therapies, a growing need for targeted biologics, the emergence of personalized protein medicines, increased usage of long-acting proteins, and advancements in protein expression systems.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2555&type=smp

What Primary Drivers Are Shaping The Development Of The Therapeutic Proteins Market?

The therapeutic protein market is anticipated to expand due to the rising occurrence of chronic illnesses, particularly diabetes. Chronic conditions are defined as health issues persisting for at least a year, interfering with daily life, or necessitating ongoing medical attention. Diabetes, a chronic ailment, involves the body’s inability to produce sufficient insulin or utilize it effectively. For managing diabetes, various protein-based treatments like insulin and GLP-1 receptor agonists are employed to control blood sugar. These therapies promote insulin secretion when blood glucose is high and concurrently diminish the output of glucagon, a hormone that elevates blood sugar. An example illustrates this: in May 2024, data from the British Diabetic Association (Diabetes UK), a charity supporting patients, healthcare professionals, and research in the UK, revealed that approximately 4.4 million individuals in the UK were diagnosed with diabetes by 2022-23. Of these, about 8% suffered from type 1 diabetes, roughly 90% had type 2 diabetes, and the remaining 2% represented other, less prevalent forms of the condition. Consequently, the growing incidence of chronic conditions like diabetes is a key factor propelling the expansion of the therapeutic protein market.

Which Segment Classifications Shape The Therapeutic Proteins Market?

The therapeutic proteins market covered in this report is segmented –

1) By Product Type: Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone

2) By Function: Enzymatic And Regulatory Activity, Special Targeting Activity, Vaccines

3) By Application: Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, Other Applications

Subsegments:

1) By Insulin: Rapid-Acting Insulin, Short-Acting Insulin, Intermediate-Acting Insulin, Long-Acting Insulin

2) By Fusion Protein: Tnf-Alpha Inhibitors, Anti-Cd20 Fusion Proteins, Other Targeted Fusion Proteins

3) By Erythropoietin: Epoetin Alpha, Darbepoetin Alfa, Other Erythropoietin Variants

4) By Interferon: Interferon Alpha, Interferon Beta, Interferon Gamma

5) By Human Growth Hormone: Somatropin, Somatrem

6) By Follicle Stimulating Hormone: Follitropin Alpha, Follitropin Beta

How Are Trends Impacting The Therapeutic Proteins Market?

Major companies operating in the therapeutic protein market are focused on introducing media systems to meet growing demand for therapeutic proteins and gain a competitive edge. These media systems for therapeutic proteins are production systems designed to optimize the generation of therapeutic monoclonal antibodies. For instance, in July 2023, Lonza Group AG, a Switzerland-based pharmaceutical manufacturing company, unveiled the TheraPRO CHO (Chinese Hamster Ovary) Media System, a novel cell culture platform intended to enhance productivity and quality in therapeutic protein manufacture. This two-part, chemically specified production technique is straightforward to use and simplifies media preparation. It offers full scalability and is supported by technical professionals with profound troubleshooting knowledge.

Which Companies Are Expanding Their Footprint In The Therapeutic Proteins Market?

Major companies operating in the therapeutic proteins market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Novartis International AG, Sanofi S.A, Bristol Myers Squibb Co., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk A/S, Baxter International Inc., Teva Pharmaceutical Industries Ltd., CSL Behring LLC, Chugai Pharmaceutical Co. Ltd., Biogen Inc., Kyowa Kirin Co. Ltd., Oramed Pharmaceuticals Inc., Sandoz International GmbH, Hualan Biological Engineering Inc., Genentech Inc., ProBiogen AG, Diasome Pharmaceuticals Inc., Generex Biotechnology Corp., GeneScience Pharmaceuticals Co. Ltd.

Read the full therapeutic proteins market report here:

https://www.thebusinessresearchcompany.com/report/therapeutic-proteins-global-market-report

How Does The Therapeutic Proteins Market Perform Across Major Global Regions?

North America was the largest region in the therapeutic proteins market in 2025. The regions covered in the therapeutic proteins market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Therapeutic Proteins Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2555&type=smp

Browse Through More Reports Similar to the Global Therapeutic Proteins Market 2026, By The Business Research Company

Protein Expression Market Report 2026

https://www.thebusinessresearchcompany.com/report/protein-expression-global-market-report

Orthobiologics Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/orthobiologics-devices-and-equipment-global-market-report

Proteomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/proteomics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795